Integrative multi-omics analysis of genomic, epigenomic, and metabolomics data leads to new insights for Attention-Deficit/Hyperactivity Disorder
Nikki Hubers, Fiona A. Hagenbeek, René Pool, Sébastien Dejean, Amy C. Harms, Peter J. Roetman, Catharina E. M. van Beijsterveldt, Vassilios Fanos, Erik A. Ehli, Robert R. J. M. Vermeiren, Meike Bartels, Jouke‐Jan Hottenga, Thomas Hankemeier, Jenny van Dongen, Dorret Irene Boomsma
This study integrates genomics, epigenomics, and metabolomics data to identify ADHD biomarkers and explore omics-level connections, finding associations between PGSs, CpGs, and metabolites.
American Journal of Medical Genetics Part B Neuropsychiatric Genetics · Aug 3, 2023Peer-reviewedGenetic & Genomic Medicine